Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06449482
Status:
RECRUITING
Last Update Posted:
2024-06-10
First Post:
2023-06-13
Brief Title:
SelinexorVenetoclax and Azactidine in the Treatment of ND AML Patients Who Are Not Eligible for Intense Chemotherapy
Sponsor:
Organization:
Institute of Hematology Blood Diseases Hospital China